MP Corporate Finance acted as the exclusive financial advisor to the shareholders in the sale of PolyCine GmbH, the leading supplier to the pharmaceutical industry of non-PVC films for intravenous therapy bags to German industrial holding group Armira.
Founded in 2002, PolyCine GmbH is today a highly reputable supplier to the pharmaceutical industry as a global leader in specialty pharma packaging. Through its unique know-how and superior production process, the company provides the most advanced PP-based pharma films and tubes for parenteral applications such as intravenous therapy (IV), parenteral nutrition, blood component bags, dialysis (CAPD) or rinsing bags. With headquarters in Schiffweiler (DE) and an export share of more than 90%, PolyCine supplies pharmaceutical manufacturers in over 30 countries globally.
In course of a succession arrangement led by MPCF, the two founders sold the company to the Munich-based industrial holding Armira. With a long-term perspective as well as entrepreneurial mindset and backed by reputable entrepreneurial families, the new owner represents an ideal partner for PolyCine to sustainably develop the company and accompany its further growth path.
Based on extensive industry knowledge the transaction team of MPCF executed a swift and tailored M&A process and closely supported PolyCine’s shareholders throughout the entire process.